Updated time: 2022-05-23 10:18:02
12A-1050308
TW I663991、EP 3432868、JP 7033582
Synthetic polymeric nanoparticles have broad applications as a carrier of active agents in numerous fields such as drug delivery and vaccine development, but the difficulty in creating a nanoscale enclosure with a large aqueous interior significantly limits platform applications involving the encapsulation of hydrophilic and macromolecular content. Existing polymeric nanoparticle platforms are generally solid with little to no internal aqueous core for hydrophilic cargo encapsulation. The thin shell hollow nanoparticles overcomes limitations of existing nanocarriers, enabling efficient encapsulation of hydrophilic molecules including macromolecules such as proteins and nucleic acids.
The invention described herein is a polymeric hollow nanoparticle platform differentiable from prior arts with defect-free polymeric shells below the thickness of 20 nm. Using polymers with defined length and sharp polarity in a double emulsion process, preparation of hollow polymeric nanoparticles with outer diameters between 600 and 30 nm are demonstrated, with polymeric shells ranging between 8 to 15 nm. It should be noted that the present invention demonstrates for the first time a hollow polymeric nanostructure below 40 nm in diameter, which is achievable only through minimization of polymeric shells. By minimizing the shell thickness, the resulting nanoparticles are also bestowed with a large interior aqueous space that can maximize the cargo loading. It is shown that in particles above 100 nm in outer diameter, the interior aqueous space can possess a diameter at least 80% of the particle’s outer diameter. High efficiency encapsulation of hydrophilic dyes, nucleic acids, and proteins are demonstrated with the thin shell hollow nanoparticles in the absence of complementary binding molecules. The thin shelled nanoparticles are demonstrated to be resistant to osmotic stress, a feature attributable to complete, defect-free polymeric shell that is impermeable to water. The present invention provides a versatile platform for the delivery of active agents with broad applications ranging from drug delivery to vaccine development.
Nanoparticles encapsulating bioactive agents have significant impact on the economy. For example, in 2004, pharmaceutical nanoformulations reached a sales figure of 6.8 billion dollars. Annually, at least 3.8 billion dollars are spent on the development of medicinal and vaccine nanotechnology. Expanding applications of nanoparticles in the fields of drug delivery, disease diagnosis, and vaccine preparation are expected exponentially increase the commercial value of nanoparticle platforms. The present invention may facilitate a large class of bioactive agents, including small molecules, peptides, nucleic acids, and proteins to be reformulated for enhanced therapeutic potency and is expected to introduce new pharmaceutical and vaccine formulations. Disease applications include but are not limited to cardiovascular disease, cancer, autoimmune disease, and infections.
Che-Ming Jack Hu, Hui-Wen Chen, Bing-Yu Yao
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Thin Shell Polymeric Hollow Nanoparticles and Uses Thereof